跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,851 条关于
“IL-17A”
全部
4,851
临床试验
2,302
药物
1,083
机构
19
资讯
1,447
去年
C4X Discovery Receives €8 Million Milestone from Sanofi for Oral IL-17A Inhibitor Progress
2个月前
Study Links Oxalate to Systemic Inflammation and Heart Damage via IL-17A Pathway in Kidney Disease
去年
Livzon's Dual-Target IL-17A/F Antibody LZM012 Outperforms Secukinumab in Phase III Psoriasis Trial
去年
Bimzelx Approved by FDA as First IL-17A and IL-17F Inhibitor for Hidradenitis Suppurativa
去年
Junshi Biosciences' IL-17A Inhibitor JS005 Meets Primary Endpoints in Phase 3 Psoriasis Trial
去年
FDA Approves UCB's Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
Bimekizumab Approved by FDA for Moderate to Severe Hidradenitis Suppurativa
去年
FDA Approves UCB's Bimzelx (bimekizumab-bkzx) for Hidradenitis Suppurativa
6个月前
FDA Approves Cosentyx for Pediatric Hidradenitis Suppurativa, Marking First IL-17A Inhibitor for Adolescents
10小时前
CHMP Backs Cosentyx for Polymyalgia Rheumatica, Setting Up First IL-17A Approval in Europe
第 1 页,共 145 页
上一页
下一页